Clearside Biomedical announces upcoming presentations on CLS-AX sub-group analyses from the ODYSSEY Wet AMD trial at various conferences. Clearside Biomedical, Inc. announced upcoming presentations ...
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today ...
CEO George Lasezkay highlighted the company's progress in advancing its suprachoroidal delivery platform, noting over 15,000 suprachoroidal injections performed to date. He announced alignment with ...
ALPHARETTA, Ga., March 20, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to ...
ALPHARETTA, Ga., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
ARLINGTON, Va. – Soldier Recovery Units are offering sports that are causing axes and arrows to fly. It’s all part of events and programs that some Soldiers participate in as part of their adaptive ...
Pianist Emanuel Ax is the featured guest of the Cleveland Orchestra this weekend, and he fulfills that role magnificently as a vibrant soloist in two short, lesser-known works for piano and orchestra.
Emanuel Ax didn’t have much time to talk Tuesday. He conducted a masterclass in the morning, was in rehearsals into the early evening, and will continue rehearsals Wednesday before his “An Evening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback